Popular on EntSun
- IRF Builders Forum Brings Global Leaders to Washington, D.C. to Advance Religious Freedom Through Cooperative Engagement - 228
- BillBoards Inc. Hits the Road with God Bless America Tour and Reality Series Now Streaming on Tubi TV - 174
- databahn Launches GenAI Sales Intelligence Platform to Revolutionize Fortune 500 and Global 2000 Account Research - 134
- Byrd Davis Alden & Henrichson Launches Independence Day Safe Ride Initiative with 500 Free Uber Credits - 126
- The ITeam Ranked on Channel Partners 2025 MSP 501—Tech Industry's Most Prestigious List of Managed Service Providers Worldwide - 120
- Revolutionary Blockchain Platform Okh Finance Announces Okh Finance(OKKH) Token Launch to Transform Global Asset Leasing Market - 119
- Agreement to Supply US-Based Defense Provider with Thin-Film Solar Tech for Orbital Application; Ascent Solar Technologies, Inc. (N A S D A Q: ASTI) - 118
- NYC Leadership Strategist Stacie Selise Launches Groundbreaking 4S Framework Series to Redefine Executive Excellence - 114
- Easton & Easton, LLP Files Suit Against The Dwelling Place Anaheim & Vineyard USA Over Abuse Allegations - 107
- Josh and Heidi Follow Up the Much Anticipated and Successful Launch of the "Spreading the Good BUZZ" Podcast with a Personal Request - 106
Similar on EntSun
- "Build Your Brand, Grow Your Business" Offers Entrepreneurs a Step-by-Step Blueprint for Success
- Pixel Studio Productions Launches Same-Day Headshots in Houston
- SeedList Launching Institutional Crypto Crowdfunding Project to Empower Retail Investors and Disrupt the VC-Dominated Crypto Fundraising Landscape
- Seligson Law Launches New Website to Support Cannabis Businesses in California and New York
- databahn Announces Subscription Access to Fortune 500 GenAI Deep Dive Sales Intelligence Reports
- AI startup Congero offers instant websites with 24/7 updates - aiming to replace web agencies
- WonderDays Launches the UK's First AI Experience Gift Finder – Gifting Just Got So Much Easier!
- Nonprofit innovator named Mensa Executive Director
- Yasmine Roulleau named Managing Director in Vancouver, Canada
- Agreement to Deliver Thin-Film Solar Technology to Space Solar Array Provider, NASA Collaborative Agreement for Orbital Applications in Power Beaming
Late Breaking Clinical Research Coming to Heart Failure Society of America Annual Scientific Meeting September 27-30
EntSun News/11035774
WASHINGTON, Sept. 5, 2024 /PRNewswire/ -- The Heart Failure Society of America (HFSA) is pleased to announce the Late Breaking Clinical Research that will be presented at its Annual Scientific Meeting (ASM), September 27-30, at the Georgia World Congress Center and the new Signia by Hilton Atlanta in Atlanta, GA.
Late breaking clinical research to be featured during two plenary sessions includes results and updates from these major randomized trials:
Sunday, September 29 Plenary Session | 9:00 AM – 10:30 AM
Monday, September 30 Plenary Session | 9:00 AM – 10:30 AM
Late Breaking Clinical Research showcases novel results of major randomized trials and rapidly evolving research. Leaders of the field will serve as discussants, presenting brief comments about each trial to place them in context.
Due to the quantity of remarkable trials submitted, HFSA will also feature late breaking research through Rapid Fire Oral Sessions. These Rapid Fire sessions are fast-paced and brief oral presentations spotlighting key data from late breaking clinical research. Sessions take place on Saturday, Sunday and Monday with moderated Q&A and a new topic each day.
Saturday, September 28 | Rapid Fire 1: Not Just Plug and Play: Devices and Health Technology in Heart Failure | 4:00 PM - 5:00 PM
Sunday, September 29 | Rapid Fire 2: Birds of a Feather: Cardio-kidney-metabolism and HFpEF | 5:15 PM - 6:15 PM
Monday, September 30 | Rapid Fire 3: See One, Do One: Emerging Therapeutic Strategies in Cardiomyopathies and Heart Failure | 10:45 AM - 11:45 AM
The meeting kicks off in just three weeks. A full schedule at a glance is available online, as well as information on the science and research and networking available at the meeting. Learn more about the meeting and register at hfsa.org/asm2024.
More on EntSun News
About the Heart Failure Society of America
The Heart Failure Society of America, Inc. (HFSA) represents the first organized effort by heart failure experts from the Americas to provide a forum for all those interested in heart function, heart failure, and congestive heart failure (CHF) research and patient care. The mission of HFSA is to provide a platform to improve and expand heart failure care through collaboration, education, innovation, research, and advocacy. HFSA members include physicians, scientists, nurses, nurse practitioners, pharmacists, trainees, other healthcare workers and patients. For more information, visit hfsa.org.
Media Contact: Laura Poko, 301-798-4493, ext. 226, [email protected]
SOURCE Heart Failure Society of America
Late breaking clinical research to be featured during two plenary sessions includes results and updates from these major randomized trials:
Sunday, September 29 Plenary Session | 9:00 AM – 10:30 AM
- STEP-HFpEF
- Efficacy Of Semaglutide In Patients With Obesity And HFpEF According To Frailty Status: A Pooled Analysis From The STEP-HFpEF Program
- Effects Of Semaglutide In Patients With Obesity-related Heart Failure With Preserved Ejection Fraction According To The Exercise Function At Baseline: Insights From The STEP-HFpEF Program
- FINEARTS-HF
- Efficacy And Safety Of Finerenone In Patients With Heart Failure And Mildly Reduced Or Preserved Ejection Fraction And A Recent Worsening Heart Failure Event: The FINEARTS-HF Trial
- Efficacy And Safety Of Finerenone Across The Ejection Fraction Spectrum In Heart Failure With Mildly Reduced And Preserved Ejection Fraction: The FINEARTS-HF Trial
- HELIOS-B
- Exploratory Analyses From HELIOS-B, A Phase 3 Study Of Vutisiran In Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Title to be announced
Monday, September 30 Plenary Session | 9:00 AM – 10:30 AM
- SEQUOIA-HCM
- Global Clinical Impact Of Aficamten In Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
- Global Clinical Impact Of Aficamten In Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
- EMBARK-HFpEF
- Myosin Inhibition In Heart Failure With Preserved Ejection Fraction: Primary Results Of The EMBARK HFpEF Trial
- Myosin Inhibition In Heart Failure With Preserved Ejection Fraction: Primary Results Of The EMBARK HFpEF Trial
- ARIES-HM3
- Impact Of Pharmacological Therapy On Hemocompatibility Following Left Ventricular Assist Device Implantation: An Analysis From The ARIES-HM3 Trial
- Impact Of Pharmacological Therapy On Hemocompatibility Following Left Ventricular Assist Device Implantation: An Analysis From The ARIES-HM3 Trial
- EXPANDed
- Atrial Secondary Mitral Regurgitation Outcomes Following Mitral Transcatheter Edge-to-Edge Repair With The MitraClip System
More on EntSun News- Exelon Leader Tamla Olivier Named 2025 Technologist of the Year by Waves of Change STEM Conference
- Be Part of the World's Largest Art Biennale | Moons, Castles, Trees | Copenhagen Chronotopes
- SeedList Launching Institutional Crypto Crowdfunding Project to Empower Retail Investors and Disrupt the VC-Dominated Crypto Fundraising Landscape
- California Family Launches Billboard to Reach "Pardon Czar" Alice Marie Johnson
- Performance Slots Available: Collision Course Concert Series Heads to Atlanta, Tampa & Brooklyn
- Atrial Secondary Mitral Regurgitation Outcomes Following Mitral Transcatheter Edge-to-Edge Repair With The MitraClip System
- HuMAIN-HFpEF
- A Novel Controlled Metabolic Accelerator For The Treatment Of Obesity-related Heart Failure With Preserved Ejection Fraction: HuMAIN-HFpEF Trial
Late Breaking Clinical Research showcases novel results of major randomized trials and rapidly evolving research. Leaders of the field will serve as discussants, presenting brief comments about each trial to place them in context.
Due to the quantity of remarkable trials submitted, HFSA will also feature late breaking research through Rapid Fire Oral Sessions. These Rapid Fire sessions are fast-paced and brief oral presentations spotlighting key data from late breaking clinical research. Sessions take place on Saturday, Sunday and Monday with moderated Q&A and a new topic each day.
Saturday, September 28 | Rapid Fire 1: Not Just Plug and Play: Devices and Health Technology in Heart Failure | 4:00 PM - 5:00 PM
- Interstitial Decongestion with Device-Based Thoracic Duct Decompression in Acute Decompensated Heart Failure Patients
- RECOVER-HFPilot Study: Synchronized Diaphragmatic Stimulation For HFrEF Therapy
- PROACTIVE HF: 12-Month Results
- Safety And Technical Endpoints And Accurate Volume Assessment Using An Implanted Inferior Vena Cava Sensor
- Electronic Alerts To Improve Heart Failure Therapy Throughout An Integrated Health System: Prompt-HF Inova
- Effect Of Finerenone On Kansas City Cardiomyopathy Questionnaire (KCCQ) Score In Heart Failure With Mildly Reduced And Preserved Ejection Fraction: The FINEARTS-HF Trial
Sunday, September 29 | Rapid Fire 2: Birds of a Feather: Cardio-kidney-metabolism and HFpEF | 5:15 PM - 6:15 PM
- Efficacy And Safety Of Finerenone According To Age In Heart Failure With Mildly Reduced And Preserved Ejection Fraction: The FINEARTS-HF Trial
- The Effects Of Burst Steroid Therapy On Short Term Decongestion In Acute Heart Failure: The CORTAHF Randomized, Open-Label, Pilot Trial
- Effects Of Exogenous Ketone Therapy On Exercise Capacity In Heart Failure With Preserved Ejection Fraction: KETO-HFpEF
- Metabolic Responses To Exercise Following Weight Loss Surgery: WTLOSS-EX Trial
- Efficacy Of A Home-Based M-Health Cardiac Rehabilitation Program Among Older Adults With Heart Failure With Preserved Ejection Fraction: A Pilot Randomized Controlled Trial
- Understanding The Real-World Management Of Patients With Heart Failure At Risk For Hyperkalemia: Initial Results From The CARE-HK In Heart Failure (HF) Registry
- Unsaturated Fatty Acids To Improve Cardiorespiratory Fitness In Obesity-Related Heart Failure With Preserved Ejection Fraction: The UFA-Preserved2 Randomized Controlled Cross-over Study
Monday, September 30 | Rapid Fire 3: See One, Do One: Emerging Therapeutic Strategies in Cardiomyopathies and Heart Failure | 10:45 AM - 11:45 AM
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study On The Safety And Efficacy Of Istaroxime For Pre-Cardiogenic Shock
- First In Human Gene Therapy For The Cardiomyopathy Of Friedreich Ataxia
- Differences In Self -care Of Heart Failure Index Among Patients With Heart Failure With And Without Symptom Coaching Messages: A Pilot Clinical Trial Study
- Efficacy Of Single Dose Furoscix Vs. Home Dose Furosemide In Patients Recently Hospitalized For Heart Failure Across Diuretic Resistance Strata: A Pilot Randomized Controlled Trial
- AuXillary OUTpatient Management Of VAD BLEEDing: The AXOUT VAD BLEED Pilot Study
- Pulmonary Artery Pressures In Relation To Serial Cardiovascular Blood Biomarkers In Chronic Heart Failure Patients
- American Registry Of Ambulatory Or Acute Decompensated Heart Failure (AMERICCAASS): Current Results
The meeting kicks off in just three weeks. A full schedule at a glance is available online, as well as information on the science and research and networking available at the meeting. Learn more about the meeting and register at hfsa.org/asm2024.
More on EntSun News
- Rent Like A Champion Acquires CollegeWeekends
- Sumter Landing Dental Care Launches Summer Special on Full Mouth Reconstruction
- Seligson Law Launches New Website to Support Cannabis Businesses in California and New York
- databahn Announces Subscription Access to Fortune 500 GenAI Deep Dive Sales Intelligence Reports
- AI startup Congero offers instant websites with 24/7 updates - aiming to replace web agencies
About the Heart Failure Society of America
The Heart Failure Society of America, Inc. (HFSA) represents the first organized effort by heart failure experts from the Americas to provide a forum for all those interested in heart function, heart failure, and congestive heart failure (CHF) research and patient care. The mission of HFSA is to provide a platform to improve and expand heart failure care through collaboration, education, innovation, research, and advocacy. HFSA members include physicians, scientists, nurses, nurse practitioners, pharmacists, trainees, other healthcare workers and patients. For more information, visit hfsa.org.
Media Contact: Laura Poko, 301-798-4493, ext. 226, [email protected]
SOURCE Heart Failure Society of America
Filed Under: Business
0 Comments
Latest on EntSun News
- Agreement to Deliver Thin-Film Solar Technology to Space Solar Array Provider, NASA Collaborative Agreement for Orbital Applications in Power Beaming
- Iterators LLC Honored with IST82 State Award for Accessibility in Massachusetts
- Josh & Heidi Share Upcoming "Spreading the Good BUZZ" Podcast Guests, Select Top Five Elopement Locations as Their Instagram Presence Grows Globally
- Opteamix Launches StackRewrite.AI to Transform Enterprise Legacy Modernization
- Planet Maldek: Watcher Files Unseals Explosive New Theory About Mars' True Origins
- DatsJustice Ignites the Industry with New Single "Dead Or Alive" & Announces 2025 Tour Kickoff
- "The Pornified Generation": Dr. Chris Samuels Exposes the Toxic Alliance Between Bro Culture and Pornography That's Rewiring a Generation
- Meet a Scientologist Builds Aussie Dreams with Mike and Jonny Hibbard
- Overwhelmed: Rick Denzien's Stark and Stirring Climate Anthem
- The 2025 ESPY Awards After Party- Presented by Poppi & High Noon
- The Modern Insurance Store Expands Medicare Help Services for Seniors in Cincinnati
- Ironside HR Named Fastest-Growing Staffing Firm for Second Year
- Inframark Continues to Build Its Community Management Capabilities and Multi-Disciplinary Presence in Arizona
- ICAST 2025: The Crystal-Clear Revolution Begins at Booth #3233
- Brindle Pet Supplies Now Carries Badlands Ranch Dog Food in Canada
- $10 Million Allocated to Establish Crypto Treasury Focused on High Value Ethereum (ETH) & Bitcoin (BTC) as Long-Term Holdings for Cybersecurity Leader
- Sing For Your Supper: A Night of Musical Comedy and Drag for a Great Cause
- Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
- $100 to $200 Million Equity Agreement with Top Digital Advisor Bitwise to Power Major Digital Asset Initiative for Bitcoin and Solana: OFA Group
- InSpired Brings World Premiere to the Weinberg Center This October